Rockefeller Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$198K	Buy	5,462 +783	+17%	+$35K	﹤0.01%	2500
2025 Q4	$218K	Buy	4,679 +521	+13%	+$23.2K	﹤0.01%	2323
2025 Q3	$173K	Buy	+4,158	New	+$133K	﹤0.01%	2302
2023 Q1	–	Sell	-1,000	Closed	-$18K	–	2363
2022 Q4	$18K	Hold	1,000	–	–	﹤0.01%	2841
2022 Q3	$19K	Buy	+1,000	New	+$20.4K	﹤0.01%	2790
2020 Q1	–	Sell	-7,066	Closed	-$177K	–	2371
2019 Q4	$177K	Buy	7,066 +4,053	+135%	+$77.2K	﹤0.01%	802
2019 Q3	$45K	Sell	3,013 -148	-5%	-$2.88K	﹤0.01%	994
2019 Q2	$79K	Hold	3,161	–	–	﹤0.01%	737
2019 Q1	$72K	Hold	3,161	–	–	﹤0.01%	834
2018 Q4	$95K	Hold	3,161	–	–	﹤0.01%	461
2018 Q3	$91K	Buy	+3,161	New	+$93.9K	﹤0.01%	398